---
title: Exploring the impact of dexamethasone on gene regulation in myeloma cells
date: '2023-07-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37524526/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230801180916&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Among glucocorticoids (GCs), dexamethasone (Dex) is widely used in treatment
  of multiple myelomas. However, despite a definite benefit, all patients relapse.
  Moreover, the molecular basis of glucocorticoid efficacy remains elusive. To determine
  genomic response to Dex in myeloma cells, we generated bulk and single-cell multi-omics
  data and high-resolution contact maps of active enhancers and target genes. We show
  that a minority of glucocorticoid receptor-binding sites are associated ...
disable_comments: true
---
Among glucocorticoids (GCs), dexamethasone (Dex) is widely used in treatment of multiple myelomas. However, despite a definite benefit, all patients relapse. Moreover, the molecular basis of glucocorticoid efficacy remains elusive. To determine genomic response to Dex in myeloma cells, we generated bulk and single-cell multi-omics data and high-resolution contact maps of active enhancers and target genes. We show that a minority of glucocorticoid receptor-binding sites are associated ...